Key result
Intracoronary transplantation of bone marrow stem cells in anterior AMI did not increase ejection fraction, but improved dipyridamole perfusion index at 6 months (2.26 vs 2.47; P=0.033).
Why the study?
Does intracoronary infusion of bone marrow stem cells improve left ventricle ejection fraction and myocardial perfusion in patients with anterior wall acute myocardial infarction?
Population
45 patients with acute myocardial infarction (AMI) of anterior wall
Comparison
Bone marrow stem cells administered into… vs Control group
Design
RCT, 2:1 to BMSC group or to control group
Follow-up
12 months
Authors
Loading...
Intracoronary BMSCs after anterior AMI may improve perfusion; leaves open LVEF benefit and clinical efficacy pending larger trials.
RCT (n=45)
2:1
Does intracoronary infusion of bone marrow stem cells improve left ventricle ejection fraction and myocardial perfusion in patients with anterior wall acute myocardial infarction?
Intracoronary bone marrow stem cell transplantation post-anterior AMI did not significantly increase LVEF but showed a slight improvement in myocardial perfusion during stress.
Grajek et al. (2009) conducted an RCT in acute myocardial infarction (AMI) of anterior wall (n=45). Bone marrow stem cells (BMSCs) vs. Control group was evaluated on Change in left ventricle ejection fraction (LVEF) and myocardial perfusion. Intracoronary transplantation of bone marrow stem cells in anterior AMI did not increase ejection fraction, but improved dipyridamole perfusion index at 6 months (2.26 vs 2.47; P=0.033).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: